Abbvie Inc

NYSE:ABBV   3:59:58 PM EDT
109.50
+1.00 (+0.92%)
4:00:00 PM EDT: $109.46 -0.04 (-0.04%)
Products

Abbvie Inc Submits Regulatory Application To FDA For RISANKIZUMAB-RZAA (SKYRIZI)

Published: 09/20/2021 13:16 GMT
Abbvie Inc (ABBV) - Abbvie Submits Regulatory Application to FDA for Risankizumab-rzaa (skyrizi®) for the Treatment of Patients 16 Years and Older With Moderate to Severe Crohn's Disease.